Stony Brook Seeks COVID-19 Survivors For Antibodies Trial
Stony Brook Medicine researchers are in need of blood donations from COVID-19 survivors. They want to see if their blood plasma contains antibodies that could help fight the disease in other patients.
A clinical trial is expected to enroll up to 500 patients who are hospitalized with COVID-19.
Stony Brook University is one of a handful of labs with approval from the U.S. Food and Drug Administration to test if the blood plasma could be a viable treatment option for the disease.
If you have recovered from COVID-19 and want to help others battling the disease by donating your blood plasma, please visit: https://www.stonybrookmedicine.edu/COVID_donateplasma.
WSHU’s Long Island News Bureau is on the campus of Stony Brook University.